We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QCOM icon
251
CALL
Qualcomm
QCOM
$171B
$18.4M 0.06%
+100,000
New +$17.3M
2026 Q3
0 quarters
KLAC icon
252
KLA
KLAC
$188B
$18.2M 0.06%
93,526
+8,037
+9% +$1.58M
2025 Q2
5 quarters
CRWD icon
253
CrowdStrike
CRWD
$244B
$18.2M 0.06%
68,721
-86,611
-56% -$18.4M
2026 Q1
2 quarters
UNH icon
254
CALL
UnitedHealth
UNH
$315B
$18.2M 0.06%
49,500
-136,300
-73% -$54.9M
2023 Q3
12 quarters
ABBV icon
255
AbbVie
ABBV
$505B
$18.2M 0.06%
69,445
-10,291
-13% -$2.64M
2026 Q2
1 quarter
TSEM icon
256
Tower Semiconductor
TSEM
$15B
$18.1M 0.06%
79,600
+29,756
+60% +$6.74M
2025 Q3
4 quarters
MPC icon
257
Marathon Petroleum
MPC
$102B
$18M 0.06%
45,450
+4,372
+11% +$1.51M
2026 Q2
1 quarter
META icon
258
PUT
Meta Platforms (Facebook)
META
$1.58T
$17.8M 0.05%
24,600
-33,700
-58% -$21M
2025 Q2
5 quarters
REGN icon
259
Regeneron Pharmaceuticals
REGN
$97.9B
$17.7M 0.05%
23,348
+1,042
+5% +$787K
2025 Q2
5 quarters
CHRW icon
260
CALL
C.H. Robinson
CHRW
$15.9B
$17.7M 0.05%
119,300
+19,300
+19% +$3.15M
2026 Q1
2 quarters
ZIM icon
261
PUT
ZIM Integrated Shipping Services
ZIM
$3.61B
$17.6M 0.05%
600,000
+300,000
+100% +$8.09M
2026 Q1
2 quarters
GWW icon
262
CALL
W.W. Grainger
GWW
$67.9B
$17.6M 0.05%
14,100
– –
2026 Q2
1 quarter
GWW icon
263
PUT
W.W. Grainger
GWW
$67.9B
$17.6M 0.05%
14,100
– –
2026 Q2
1 quarter
SORNU icon
264
Soren Acquisition Corp Unit
SORNU
$17.3M 0.05%
1,700,000
– –
2026 Q1
2 quarters
CGCFU
265
Cartesian Growth Corp IV Unit
CGCFU
$17.3M 0.05%
1,750,000
– –
2026 Q2
1 quarter
BACC icon
266
Blue Acquisition Corp
BACC
$293M
$17.3M 0.05%
1,650,000
-265,455
-14% -$2.8M
2025 Q4
3 quarters
WMT icon
267
Walmart
WMT
$1.01T
$17.2M 0.05%
165,950
+160,853
+3,156% +$17.7M
2025 Q4
3 quarters
IPFX icon
268
Inflection Point Acquisition Corp VI
IPFX
$366M
$17.1M 0.05%
1,700,000
– –
2026 Q2
1 quarter
FLEX icon
269
CALL
Flex
FLEX
$27.6B
$17.1M 0.05%
+155,300
New +$18.4M
2026 Q3
0 quarters
CGON icon
270
CALL
CG Oncology
CGON
$7.14B
$16.9M 0.05%
238,700
+114,800
+93% +$8.44M
2026 Q2
1 quarter
BCCQ icon
271
Bleichroeder Acquisition Corp III
BCCQ
$415M
$16.9M 0.05%
+1,700,000
New +$17M
2026 Q3
0 quarters
QRVO icon
272
DELISTED
Qorvo
QRVO
$16.8M 0.05%
146,833
-512,357
-78% -$50.3M
2024 Q3
8 quarters
NKE icon
273
Nike
NKE
$53.8B
$16.8M 0.05%
474,404
+407,385
+608% +$16.4M
2025 Q4
3 quarters
BWA icon
274
CALL
BorgWarner
BWA
$10B
$16.7M 0.05%
278,600
+200,000
+254% +$12.9M
2026 Q2
1 quarter
CMCSA icon
275
Comcast
CMCSA
$89.8B
$16.6M 0.05%
761,379
+216,890
+40% +$5.31M
2024 Q4
7 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.